Skip to content

Charles River Laboratories CRL Balance Sheet Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$198.2M-8.2%$216M+3.2%$209.22M+13.3%$184.74M-20.3%$231.73M+12.7%
$708.37M-1.5%$719.32M-3.9%$748.29M-4.1%$780.41M+1.0%$772.89M+4.6%
$359.72M+20.3%$299.1M-1.1%$302.55M+8.2%$279.55M-3.7%$290.16M+4.2%
$1.49B+2.9%$1.45B-5.6%$1.53B+4.2%$1.47B-2.4%$1.51B+7.4%
$1.51B-8.8%$1.66B+4.0%$1.59B-0.9%$1.61B+1.2%$1.59B-1.1%
$3.04B+10.0%$2.76B-5.4%$2.92B-0.5%$2.94B+2.2%$2.87B+0.9%
$248.99M-26.8%$340M-40.5%$571.09M-5.2%$602.45M-8.1%$655.71M-9.4%
$7.73B+8.3%$7.14B-5.0%$7.51B-0.6%$7.56B-0.3%$7.58B+0.7%
$133.95M-10.0%$148.8M-12.3%$169.62M+16.3%$145.8M-2.4%$149.33M+6.4%
$194.33M-7.6%$210.42M-11.5%$237.73M-11.4%$268.34M+7.1%$250.46M+0.9%
$6.7M+3,936%$166K+207%$54K-44.9%$98K-19.0%$121K-21.9%
$1.09B-2.4%$1.12B-0.1%$1.12B+3.8%$1.08B+2.8%$1.05B+5.7%
$2.66B+24.7%$2.14B-2.2%$2.19B-6.3%$2.33B-7.1%$2.51B+12.1%
$30M0.0%$30M-99.3%$4.06B-2.4%$4.16B-4.1%$4.34B+8.0%
120M0.0%120M0.0%120M0.0%120M0.0%120M+23,383%
$1.37B-1.1%$1.39B-28.6%$1.94B+2.9%$1.89B+2.8%$1.84B+1.4%
$2.94B-7.1%$3.16B-7.1%$3.41B+1.6%$3.35B+5.0%$3.19B-7.7%
$7.73B+8.3%$7.14B-5.0%$7.51B-0.6%$7.56B-0.3%$7.58B+0.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Charles River Laboratories's total assets?
Charles River Laboratories (CRL) holds $7.7B in total assets, up 1.9% year over year.
How much debt does Charles River Laboratories have?
Charles River Laboratories carries $3.1B in total debt against $2.9B of shareholders' equity, a debt-to-equity ratio of 1.05.
How much cash does Charles River Laboratories have?
Charles River Laboratories holds $198.2M in cash and equivalents.
Can Charles River Laboratories cover its short-term obligations?
Its current ratio is 1.36 — current assets exceed current liabilities.
Where does Charles River Laboratories's balance sheet data come from?
Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.